X-linked agammaglobulinemia epidemiology and demographics

Jump to navigation Jump to search

X-linked agammaglobulinemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating X-linked agammaglobulinemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Serology

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

X-linked agammaglobulinemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of X-linked agammaglobulinemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on X-linked agammaglobulinemia epidemiology and demographics

CDC on X-linked agammaglobulinemia epidemiology and demographics

X-linked agammaglobulinemia epidemiology and demographics in the news

Blogs on X-linked agammaglobulinemia epidemiology and demographics

Directions to Hospitals Treating X-linked agammaglobulinemia

Risk calculators and risk factors for X-linked agammaglobulinemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

XLA is an X-linked disorder, and therefore is almost always limited to males. It occurs in a frequency of about 1 in 100,000 male newborns, and has no ethnic predisposition.

References

Template:WH Template:WS